Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mariya, Likhter"'
Autor:
Eyal Klang, Shelly Soffer, Lee Alper, Orit Shimon, Yiftach Barash, Yana Davidov, Mariya Likhter, Oranit Cohen‐Ezra, Gil Ben Yakov, Ziv Ben‐Ari
Publikováno v:
Health Science Reports, Vol 5, Iss 6, Pp n/a-n/a (2022)
Abstract Background Hepatits C virus (HCV) rates have lowered due to direct‐acting antiviral treatment. Nonalcoholic steatohepatitis (NASH)/nonalcoholic fatty liver disease (NAFLD) is rising with no available therapy. We employed text‐mining to a
Externí odkaz:
https://doaj.org/article/116092bc0fe3472dbc250877277f9c0d
Autor:
Yana Davidov, Victoria Indenbaum, Michal Mandelboim, Keren Asraf, Tal Gonen, Keren Tsaraf, Oranit Cohen-Ezra, Mariya Likhter, Ital Nemet, Limor Kliker, Orna Mor, Ram Doolman, Carmit Cohen, Arnon Afek, Yitshak Kreiss, Gili Regev-Yochay, Yaniv Lustig, Ziv Ben-Ari
Publikováno v:
Viruses, Vol 15, Iss 1, p 253 (2023)
The immune responses of liver transplant (LT) recipients after the third boost of the BNT162b2mRNA vaccine improved. This study evaluates the durability of the immune response of LT recipients after the third boost, its predictors, and the impact of
Externí odkaz:
https://doaj.org/article/fab4e5641ad844b09243a5cfb32c0b24
Autor:
Yana Davidov, Victoria Indenbaum, Nofar Atari, Limor Kliker, Keren Tsaraf, Keren Asraf, Oranit Cohen-Ezra, Mariya Likhter, Orna Mor, Ram Doolman, Yael Weiss-Ottolenghi, Tammy Hod, Arnon Afek, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim, Ziv Ben-Ari
Publikováno v:
Viruses, Vol 14, Iss 12, p 2769 (2022)
The immune response of liver transplant (LT) recipients to a third dose of the BNT162b2 mRNA vaccine significantly waned after four months. We aimed to evaluate the immune response and breakthrough infection rates of a fourth dose against the Omicron
Externí odkaz:
https://doaj.org/article/d4bb7d5d1a444b8d95a88084394f0daf
Autor:
Keren Tsaraf, Yaniv Lustig, Einav G Levin, Itzchak Levy, Yana Davidov, Mariya Likhter, Orna Mor, Oranit Cohen-Ezra, Galia Rahav, Ziv Ben Ari, Gil Ben Yakov
Publikováno v:
Liver Transplantation
The BNT162b2 messenger RNA (mRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been shown to be safe and effective in immunocompetent patients. The safety and efficacy of this vaccine in liver transplantation (
Autor:
Yana, Davidov, Yeruham, Kleinbaum, Yael, Inbar, Oranit, Cohen-Ezra, Ella, Veitsman, Peretz, Weiss, Mariya, Likhter, Tania, Berdichevski, Sima, Katsherginsky, Avishag, Hassid, Keren, Tsaraf, Dana, Silverberg, Ziv, Ben Ari
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(12)
New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.To determine the effect of
Autor:
Yana Davidov, Victoria Indenbaum, Keren Tsaraf, Oranit Cohen-Ezra, Mariya Likhter, Gil Ben Yakov, Rebecca Halperin, Itzchak Levy, Orna Mor, Nancy Agmon-Levin, Arnon Afek, Galia Rahav, Yaniv Lustig, Ziv Ben Ari
Publikováno v:
Journal of hepatology. 77(3)
Immune responses of solid organ transplant recipients to 2 doses of the BNT162b2 mRNA anti-SARS-CoV-2 vaccine are impaired. The immunogenicity and safety of a third dose among liver transplant (LT) recipients are unknown. This work aimed to evaluate
Autor:
Yana Davidov, Victoria Indenbaum, Keren Tsaraf, Oranit Cohen-ezra, Mariya Likhter, Gil Ben Yaacov, Rebecca Halperin, Itzchak Levy, Orna Mor, Nancy Agmon-Levin, Arnon Afek, Galia Rahav, Yaniv Lustig, Ziv Ben Ari
Publikováno v:
Journal of Hepatology. 77:S784
Autor:
Ido Yofe, Shir Shlomi-Loubaton, Yana Davidov, Oranit Cohen-Ezra, Oren Barboy, Diego Jaitin, David Goitein, Dominik Pfister, Aleksandra Deczkowska, Amir Giladi, Merav Cohen, Chamutal Gur, Mathias Heikenwalder, Michael Safran, Susanne Roth, Sandrine Henri, Assaf Weiner, Eylon Lahat, Ziv Ben-Ari, Gil Ben Yakov, Bernard Malissen, Mengjie Qiu, Ido Amit, Shing Kam, Hila Hermon, Yousuf Suhail, Mariya Likhter, Achim Weber, Eran Elinav, Eyal David, Pierluigi Ramadori
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2021, ⟨10.1038/s41591-021-01344-3⟩
Nature Medicine, 2021, ⟨10.1038/s41591-021-01344-3⟩
Nature Medicine, Nature Publishing Group, 2021, ⟨10.1038/s41591-021-01344-3⟩
Nature Medicine, 2021, ⟨10.1038/s41591-021-01344-3⟩
International audience; Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver failure and liver cancer. Chronic necro-infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a635b1f210791c3fa08beb091c7565
https://hal.archives-ouvertes.fr/hal-03234079
https://hal.archives-ouvertes.fr/hal-03234079
Autor:
Aleksandra, Deczkowska, Eyal, David, Pierluigi, Ramadori, Dominik, Pfister, Michal, Safran, Baoguo, Li, Amir, Giladi, Diego Adhemar, Jaitin, Oren, Barboy, Merav, Cohen, Ido, Yofe, Chamutal, Gur, Shir, Shlomi-Loubaton, Sandrine, Henri, Yousuf, Suhail, Mengjie, Qiu, Shing, Kam, Hila, Hermon, Eylon, Lahat, Gil, Ben Yakov, Oranit, Cohen-Ezra, Yana, Davidov, Mariya, Likhter, David, Goitein, Susanne, Roth, Achim, Weber, Bernard, Malissen, Assaf, Weiner, Ziv, Ben-Ari, Mathias, Heikenwälder, Eran, Elinav, Ido, Amit
Publikováno v:
Nature medicine. 27(6)
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver failure and liver cancer. Chronic necro-inflammation is a critical fa
Autor:
Omry Koren, Michal Safran, Ella Veitsman, Mariya Likhter, Yelena Lapidot, Shira Ben-Simon, Peretz Weiss, Ziv Ben Ari, Oranit Cohen-Ezra, Yana Davidov
Publikováno v:
Journal of Hepatology. 70:e516-e517